Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vascular Effects of Single E-Cigarette Use
NCT03209661Phase 1Completed
- Sponsor
- University of Texas at Austin
- Start
- Apr 2017
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial (3 arms), sponsored by University of Texas at Austin. Primary endpoints: Cardio-Ankle Vascular Index at 2 hour and Flow Mediated Dilation at 2 hour. Started Apr 2017; status: completed.
Beyond the preview
Go deeper on NCT03209661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03209661.